Breaking
RAPS Euro Convergence: Top Regulatory Insights - Day 1European Research Revolution: Day 1 HighlightsRAPS Euro Convergence: Key Regulatory Updates - Day 1
🇪🇺 EMA

Endocrinology

Page 1 • 1 item

Gain critical insights into global endocrinology drug development, clinical trials, regulatory approvals, and market trends. Inform your pharma strategy.

Crinetics Pharmaceuticals Receives EU Approval for PALSONIFY (Paltusotine), First Oral Daily Acromegaly Treatment
NewsEndocrinology - AcromegalyApr 28, 2026

Crinetics Pharmaceuticals Receives EU Approval for PALSONIFY (Paltusotine), First Oral Daily Acromegaly Treatment

Crinetics Pharmaceuticals announces European Commission approval of PALSONIFY (paltusotine), the first once-daily oral therapy for acromegaly in adults.

Matteo Ricci